Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
New preclinical data further characterizes EQ504’s coordinated effects across epithelial and immune compartments in intestinal inflammation New preclinical data further characterizes EQ504’s coordinated effects across epithelial and immune compartments in intestinal inflammation
Covered in this story
Call it yourself
No calls on $EQ yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Equillium →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.